Company intelligence / Profile preview

SweTree Technologies

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

SweTree Technologies develops innovative biotechnologies to improve tree growth, wood properties, disease resistance, and resource efficiency. Their platforms are being commercialized with support from major forestry companies. They have a strong IP portfolio (>150 patents/applications) and are building the world’s first large-scale automated factory for fast-growing forest plants using somatic embryogenesis. The first such facility aims to produce up to 20 million plants per year by ~2028.

Modalities: Precision breedingAutomated somatic embryogenesis plant propagationGenetic modificationClonal propagation
Industry: Agriculture & AgTech

Partnerships

Stora EnsoSveaskogSCASödraHolmenUmeå Plant Science CentreWoodheads innovation network

Beyond the preview

Go deeper on SweTree Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SweTree Technologies.

Explore the full profile